ClinicalTrials.Veeva

Menu

Comparison of Deep Neuromuscular Block and Moderate Neuromuscular Block on Quality of Recovery in Patients Undergoing Robotic Gastrectomy

Yonsei University logo

Yonsei University

Status

Completed

Conditions

General Anesthesia

Treatments

Drug: Moderate neuromuscular blockade
Drug: Deep neuromuscular blockade

Study type

Interventional

Funder types

Other

Identifiers

NCT02762890
4-2016-0206

Details and patient eligibility

About

The purpose of this study is to investigate and compare the postoperative quality of recovery between the deep neuromuscular blockade and moderate neuromuscular blockade during robotic gastrectomy.

Enrollment

56 patients

Sex

All

Ages

19 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adult patients aged 19-80 years who are scheduled for robotic gastrectomy

Exclusion criteria

  • Neuromuscular disease
  • History of malignant hyperthermia
  • Significant renal or hepatic dysfunction
  • Allergy to sugammadex or rocuronium

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

56 participants in 2 patient groups

Deep neuromuscular blockade
Experimental group
Description:
Rocuronium will be administered continuously to achieve post-tetanic count 1-2 during surgery.
Treatment:
Drug: Deep neuromuscular blockade
Moderate neuromuscular blockade
Active Comparator group
Description:
Rocuronium will be administered continuously to achieve Train-of-four 1-2 during surgery.
Treatment:
Drug: Moderate neuromuscular blockade

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems